Month: August 2011

Li3 Energy Establishes $18 Million Exploration and Development Plan

August 30, 2011 0

Li3 Energy Establishes $18 Million Exploration and Development Plan Initiates $8 Million Phase One To Advance the Maricunga Project PR Newswire SANTIAGO, Chile, Aug. 30, 2011 SANTIAGO, Chile , Aug. 30, 2011 /PRNewswire/ — Li3 Energy, Inc., (OTCBB: LIEG –News) (“Li3”, “Li3 Energy” or the “Company”), a US-listed and South American based global exploration company in the lithium and minerals sector, is pleased to announce it has established a $18MM exploration and development plan for its Maricunga project […]

Momentum Stocks

VistaPrint NV (VPRT) – Bear of the Day (VPRT)

August 30, 2011 0

While VistaPrint NV's ( VPRT ) earnings for the fourth quarter of fiscal 2011 were well ahead of the Zacks Consensus Estimate, we believe that the slow pace of the economic recovery coupled with huge investments in 2012 and 2013 to attract customers will restrict improvements in its top as well as bottom lines. The new set of initiatives also involves increased risks and lack of visibility toward return on investments at the current level. […]

Momentum Stocks

Darling International, Inc. – Momentum (DAR)

August 30, 2011 0

Darling International, Inc. ( DAR ) has seen huge gains over the last year, more than doubling in price after recently hitting a new 52-week high on another solid earnings surprise. With estimates moving higher on the news, this Zacks #1 rank stock is a solid pick for momentum. […]

Stock Analysts

Louisiana-Pacific Cuts Production (LPX) (UFPI) (WY)

August 29, 2011 0

Louisiana-Pacific Corporation ( LPX ) recently announced the curtailment of oriented strand board (OSB) press production at its Dawson Creek mill, located in British Columbia, Canada. However, the mill will continue to manufacture LP TechShield Radiant Barrier Sheathing to support the demand of the product i n the W est Coast markets. […]

Stock Analysts

Simcere Drug Cleared in China (BMY) (JNJ) (MRK) (PFE) (SCR)

August 29, 2011 0

Recently, the State Food and Drug Administration (SFDA) of China delivered a boost to Simcere Pharmaceutical Group ( SCR ) by clearing its drug Iremod, for treating patients suffering from active rheumatoid arthritis (RA). Iremod, developed solely by Simcere, will be the first Iguratimod drug to hit the global market and will be used mainly to treat patients suffering from active RA. […]